抗NMDA受体脑炎患者的长度残疾,认知障碍和情绪症状

Annalisa Morgan1, Yadi Li1, Nicolas R Thompson1

  • 1From the Department of Neurology, Neurological Institute (A. Morgan, J.R.A., J.A.C., D.O., V.P., A.K.), Department of Quantitative Health Sciences, Lerner Research Institute (Y.L., N.R.T., A. Milinovich), Center for Outcomes Research and Evaluation, Neurological Institute (Y.L., N.R.T.), Mellen Center for Multiple Sclerosis Treatment and Research, Neurological Institute (J.R.A., J.A.C., D.O., R.G., A.K.), Charles Shor Epilepsy Center, Neurological Institute (V.P.), Cleveland Clinic; and Cleveland Clinic Lerner College of Medicine (A.R.-G.), OH.

Neurology
|January 24, 2024
PubMed
概括

抗NMDA受体脑炎 (anti-NMDARe) 的长度结局显示显著的长期损伤,特别是在认知和情绪方面,修改后的兰金度量表 (mRS) 无法捕捉到这一点. 使用诸如自身免疫性脑炎临床评估尺度 (CASE) 等措施进行增强的评估对于全面理解至关重要.